RCT for Transvaginal Self-cut Mesh vs Mesh-kit for Severe POP
- Conditions
- Pelvic Organ Prolapse
- Interventions
- Procedure: pelvic floor reconstructive surgery
- Registration Number
- NCT03849157
- Lead Sponsor
- Peking Union Medical College Hospital
- Brief Summary
Pelvic organ prolapse(POP) is a common health problem and has significant negative effects on woman's quality of life. Transvaginal mesh procedure is a durable reconstructive surgery, but the mesh kits are expensive for underdeveloped countries. Our preliminary trial showed that the use of self-tailored mesh had good success rate (91.8% at 1-year follow-up) and low complication rate. The trial is designed to compare self-tailored titanium-coated polypropylene mesh procedure with mesh-kit in the treatment of POP stage III-IV in terms of efficacy, safety and cost-effective .
- Detailed Description
The trial is a randomized controlled multi-center non-inferiority trial. The primary outcome measure is success rate at 1-year follow-up. The second outcomes are subjective improvement of quality of life, complications and costs. Analysis will be performed according to the intention to treat principle. Based on comparable success rate of 90% and 10% as the margin(beta 0.2 and one sided alpha 0.025), about 312 patients in total from 11 centers will be recruited per group including 10% drop-out. The aims of the research are to demonstrate whether self-tailored mesh is non-inferior to the mesh-kit. The finding of this research might influence the treatment selection for POP in China.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 312
- Age:More than 50 year with more than 3 years after menopause, or more than 55 years old, but less than 75 years old.
- Subject must have severe apical or anterior vaginal prolapse (stage III-IV), with moderate posterior vaginal prolapse(stage I-II). This is defined as ( C > +1cm OR Ba > +1cm, with Bp ≤+1cm by the POP-Q). This is the most common modality of multiple compartment POP in clinic.
- Subject reports a bothersome bulge they can see or feel per PFDI-20, question 3, response of 2 or higher (i.e., responses of "somewhat", "moderately", or "quite a bit").
- Desires transvaginal mesh treatment for primary or recurrent, symptomatic uterovaginal prolapse.
- Concomitant hysterectomy when indicated. But concomitant anti-incontinence surgeries will not be enrolled.
- Subject is willing and able to comply with the follow-up regimen.
- Subject is pregnant or intends to become pregnant in the future
- Subject has an active or chronic systemic infection including any gynecologic infection, untreated urinary tract infection (UTI) or tissue necrosis
- Subject has history of pelvic organ cancer (e.g. uterine, ovarian, bladder, colo-rectal or cervical)
- Subject has had prior or is currently undergoing radiation, laser therapy, or chemotherapy in the pelvic area
- Subject has taken systemic steroids (within the last month), or immunosuppressive or immunomodulatory treatment (within the last 3 months)
- Subject has systemic connective tissue disease (e.g. scleroderma, systemic lupus erythematosus (SLE), Marfan syndrome, Ehlers Danlos, collagenosis, polymyositis, polymyalgia rheumatica)
- Subject has chronic systemic pain that includes the pelvic area or chronic focal pain that involves the pelvis
- Subject has uncontrolled diabetes mellitus (DM)
- Subject has a known neurologic or medical condition affecting bladder function (e.g., multiple sclerosis, spinal cord injury or stroke with residual neurologic deficit)
- Subject has had previous prolapse repair with mesh in the target compartment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description self-cut mesh procedure pelvic floor reconstructive surgery This procedure is transvaginal mesh implantation surgery for POP patients. Self-cut mesh procedure is an economic pelvic reconstructive surgical operation with use of specially designed puncture needles and self-cut mesh, which mainly provide anterior and apical compartments support, with posterior compartment reinforced by bridge technique repair. The mesh pieces used in this surgery was cut from a single piece of mesh material(TiLOOP 10\*15cm) which is much cheaper and readily available. Patients could have transvaginal hysterectomy concomitantly. mesh-kit procedure pelvic floor reconstructive surgery This procedure is transvaginal mesh implantation surgery for POP patients.Mesh-kit procedure is refered to pelvic floor reconstructive surgery with titanium-coated meshes kit(TiLOOP TOTAL6).Patients could have transvaginal hysterectomy concomitantly.
- Primary Outcome Measures
Name Time Method surgical "success" up to 36 months after operation Subjects will be considered a success if they meet the definitions of anatomic cure and deny vaginal bulging symptoms, and no additional treatment for prolapse(surgical or pessary use).
Anatomic cure is defined as leading edge above the hymen (i.e Ba, C, Bp\<0 cm) Symptomatic cure is defined as the absence of vaginal bulge symptoms as indicated by a negative response question 3 of the pelvic floor distress inventory- 20 (PFDI-20): "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?
- Secondary Outcome Measures
Name Time Method symptomatic improvement using validated instruments(PISQ-12) up to 36 months after operation Relief of symptoms using validated instruments(PISQ-12)
symptomatic improvement using validated instruments(PFDI-20) up to 36 months after operation Relief of symptoms using validated instruments(PFDI-20) .
intraoperative and post operative complications up to 36 months after operation using IUGA/ICS joint terminology CTS coding system and dingo system
symptomatic improvement using validated instruments(PFIQ-7) up to 36 months after operation Relief of symptoms using validated instruments(PFIQ-7) .
anatomic outcomes up to 36 months after operation anatomic outcome of each vaginal segment( anterior, posterior and apical) using POP-Q score.
symptomatic improvement using patient global impression of change (PGI-C) up to 36 months after operation Relief of symptoms using patient global impression of change (PGI-C)
post operative pain within 3 days after operation visual analogue scales (VAS) were used to evaluate the degree of pain.
Trial Locations
- Locations (11)
Peking Union Medical College Hospital
🇨🇳Beijing, Beijing, China
Fosha Maternal and Child Health Care Hospital
🇨🇳Foshan, Guangdong, China
The First Affiliated Hospital of Guangzhou Medical College
🇨🇳Guangzhou, Guangdong, China
Changsha Maternal and Child Health Care Hospital
🇨🇳Changsha, Hunan, China
The second Xiangya Hospital of Central South University
🇨🇳Changsha, Hunan, China
Wuxi Maternal and Child Health Care Hospital
🇨🇳Wuxi, Jiangsu, China
Qilu Hospital of Shandong University
🇨🇳Jinan, Shandong, China
Shanxi Provincial People's Hospital
🇨🇳Xi'an, Shanxi, China
Sichuan University West China Second University Hospital
🇨🇳Chengdu, Sichuan, China
the First Affiliated Hospital of Xinjiang Medical University
🇨🇳Ürümqi, Xinjiang, China
the People's Hospital of Xinjiang Uygur Autonomous Region
🇨🇳Ürümqi, Xinjiang, China